Quest Diagnostics Incorporated Financials

Market Capitalization $16.95 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	20.41
Forward PE	15.56
Price to Sales TTM	$1.78
Price to Book MRQ	$2.50
Enterprise to Revenue	2.44
Enterprise to EBITDA	12.89

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	8.82%
Operating Margin	14.19%
Return on Assets TTM	5.66%
Return on Equity TTM	13.22%

Income Statement

Revenue TTM	$9,539,000,320
Revenue per Share TTM	$85.74
Quarterly Revenue Growth	8.40%
Gross Profit TTM	$3,144,999,936
EBITDA	$1,780,000,000
Net Income to Common TTM	$838,000,000
Diluted EPS TTM	$7.44
Quarterly Earnings Growth YoY	0.40%

Balance Sheet

Total Cash MRQ	$764,000,000
Total Cash per Share MRQ	$6.85
Total Debt MRQ	$
Total Debt to Equity MRQ	100.71
Current Ratio MRQ	1.25
Book Value per Share MRQ	$60.80

Cash Flow

Operating Cash Flow TTM	$1,396,999,936
Levered Free Cash Flow TTM	$853,249,984

DGX Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	111,615,000
Float Shares	110,691,007
Avg 10 Volume	812,250
Avg 30 Volume	None
Shares Short	2,032,747
Short Ratio	2.64
Short % of Shares	2.08%
% Held by Insiders	0.43%
% Held by Institutions	91.94%

Stock Price Summary

Beta	0.89
Fifty Two Week Low	$123.04
Fifty Two Week High	$165.32
Fifty Two Week Change	16.71%
Day 50 MA	$156.27
Day 200 MA	$148.04

Dividends and Splits

Forward Annual Dividend Rate	$3.00
Forward Annual Dividend Yield	1.93%
Trailing Annual Dividend Rate	$3.00
Trailing Annual Dividend Yield	1.93%
Payout Ratio	39.78%
Dividend Date	2025-01-29
Ex Dividend Date	2025-01-14
Last Split Factor
Last Split Date	2005-06-21